Literature DB >> 14499697

Identification of germline MSH2 gene mutations in endometrial cancer not fulfilling the new clinical criteria for hereditary nonpolyposis colorectal cancer.

Kouji Banno1, Nobuyuki Susumu, Takeshi Hirao, Megumi Yanokura, Akira Hirasawa, Daisuke Aoki, Yasuhiro Udagawa, Kokichi Sugano, Shiro Nozawa.   

Abstract

Endometrial cancer is the second most common malignancy in patients with hereditary nonpolyposis colorectal cancer (HNPCC). This cancer is caused by germline mutations in one of the DNA mismatch repair (MMR) genes. The present study was undertaken to analyze the relation between microsatellite instability (MSI) and germline mutations of MMR genes. We analyzed MSI in 38 cases of endometrial cancer. MSI was present in one or more (out of 5 examined) regions in 11 (29%) cases. Furthermore, alterations in MLH1 and MSH2, two culprit genes representative of HNPCC, were examined in the 11 MSI-positive patients using polymerase chain reaction-single-strand conformation polymorphism and sequencing. Germline mutations, namely, 1) a missense mutation at codon 688 (ATG-->ATA, Met-->Ile) and 2) a missense mutation at codon 390 (CTT-->TTT, Leu-->Phe) of the MSH2 gene, were found in 2 of the 11 patients (18%). Although these two cases do not fulfill the new Amsterdam criteria, they had strong family histories of colorectal and endometrial carcinoma. Our results show that genetic testing is important in cases of endometrial cancer with a history suggestive of HNPCC even if the new Amsterdam criteria are not fulfilled.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499697     DOI: 10.1016/s0165-4608(03)00157-2

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  Three novel missense germline mutations in different exons of MSH6 gene in Chinese hereditary non-polyposis colorectal cancer families.

Authors:  Shi-Yan Yan; Xiao-Yan Zhou; Xiang Du; Tai-Ming Zhang; Yong-Ming Lu; San-Jun Cai; Xiao-Li Xu; Bao-Hua Yu; Heng-Hua Zhou; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

2.  The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.

Authors:  Juana V Martín-López; Ysamar Barrios; Vicente Medina-Arana; Miguel Andújar; Sanghee Lee; Liya Gu; Guo-Min Li; Josef Rüschoff; Eduardo Salido; Richard Fishel
Journal:  Carcinogenesis       Date:  2012-06-27       Impact factor: 4.944

3.  Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard.

Authors:  Sining Chen; Patrice Watson; Giovanni Parmigiani
Journal:  Biostatistics       Date:  2005-04-14       Impact factor: 5.899

4.  hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications.

Authors:  Yuning Xiong; Sean C Dowdy; Norman L Eberhardt; Karl C Podratz; Shi-Wen Jiang
Journal:  Gynecol Oncol       Date:  2006-05-15       Impact factor: 5.482

5.  Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae.

Authors:  Alison E Gammie; Naz Erdeniz; Julia Beaver; Barbara Devlin; Afshan Nanji; Mark D Rose
Journal:  Genetics       Date:  2007-08-24       Impact factor: 4.562

6.  Relationship of lower uterine segment cancer with Lynch syndrome: a novel case with an hMLH1 germline mutation.

Authors:  Kenta Masuda; Kouji Banno; Akira Hirasawa; Megumi Yanokura; Kosuke Tsuji; Yusuke Kobayashi; Iori Kisu; Arisa Ueki; Hiroyuki Nomura; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Oncol Rep       Date:  2012-08-31       Impact factor: 3.906

7.  Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis.

Authors:  Takashi Takeda; Kouji Banno; Megumi Yanokura; Masataka Adachi; Moito Iijima; Haruko Kunitomi; Kanako Nakamura; Miho Iida; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Yusuke Kobayashi; Wataru Yamagami; Akira Hirasawa; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Genes (Basel)       Date:  2016-10-14       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.